Ontario’s medical regulator has paused enforcement of new safer supply prescribing rules after receiving a legal challenge seeking to block them, according to Canadian Press reporting published by Global News.

The College of Physicians and Surgeons of Ontario said it was served Friday with legal action that includes a motion for an injunction. The changes were scheduled to take effect Monday, Nov. 16, but the college said it is holding off on enforcement to allow time to respond to that motion.

The pause is a step taken by the regulator in response to the legal action, rather than a reported court ruling on whether the prescribing requirements can proceed.

Approved last month, the changes would require doctors to prescribe safer supply medications only in conjunction with opioid agonist therapy. They would also require patients to take their safer supply medications in front of health-care professionals instead of taking them home.

Safer supply medications are provided to people at high risk of overdose as an alternative to illicit opioids. Opioid agonist therapy uses medications, including Suboxone and methadone, to treat opioid addiction. The college’s new requirements would link safer supply prescribing to that treatment.

The supervised-consumption requirement has raised concerns about access, particularly for patients in rural Ontario and people who work regular hours. Those concerns centre on the requirement to take medication in the presence of a health-care professional rather than having a take-home supply.

The college has said its changes are intended to reduce the diversion of prescribed safer supply opioids to the streets. Its board chair, Dr. Patrick Safieh, has said Ontario police forces are noticing patients’ safer supply drugs being diverted to the black market.

For now, enforcement remains paused while the college prepares its response to the injunction request.

Sources